Previous studies demonstrate that NANOG is highly expressed in GC and significantly associated with tumor size and grade, along with decreased overall survival (Iv Santaliz-Ruiz et al., 2014; Basati et al., 2020). The gene discussed is NANOG; the disease is gastric cancer.